Ropes & Gray advised Solid Biosciences on the transaction. Solid Biosciences (Nasdaq: SLDB), a biotechnology company specializing in genetic medicines for neuromuscular and cardiac diseases, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Accutar Biotechnology on the transaction. Accutar Biotechnology announced a partnership with Evommune focused on the discovery of novel small molecule drug candidates in...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented CANbridge Pharmaceuticals on the deal. CANbridge Pharmaceuticals, a China-based biopharmaceutical company, announced its exclusive worldwide license agreement with UMass Chan Medical School relating...
You must be a Standard 1 Year member to access this content.
